ClinicalTrials.Veeva

Menu

Evaluation of a Twenty-session Cognitive-behavioral Therapy With Anorexia Nervosa (CBT-20-AN) Among Adults (18+)

Mass General Brigham logo

Mass General Brigham

Status

Invitation-only

Conditions

Anorexia Nervosa

Treatments

Behavioral: Twenty Session Cognitive-Behavioral Therapy for Anorexia Nervosa (CBT-20-AN)

Study type

Interventional

Funder types

Other

Identifiers

NCT06597305
2023P002713

Details and patient eligibility

About

The study is a clinical trial assessing the efficacy of a new twenty session cognitive behavioral therapy for adults (18+) with anorexia nervosa (AN). It is expected that participants will gain a significant amount of weight and experience a significant decrease in eating disorder psychopathology and behavior from pre- to post- treatment and that this will be retained after 6-months.

Enrollment

20 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Eligible patients must meet DSM-5 criteria for anorexia nervosa. This diagnosis can be conferred via the EDE 17.0D.
  2. Age > 18
  3. Patients must be able to provide informed consent and comply with the study procedures.
  4. Patients must be able to complete computer-based self-report questionnaires with adequate accommodation, if necessary.
  5. Patients must have a primary care physician, Adolescent Medicine physician, or consulting physician with eating disorder expertise at Massachusetts General Hospital/Massachusetts General Brigham network who can provide ongoing medical monitoring while the patient takes part in the study.

Exclusion criteria

Patients will be excluded if they exhibit:

  1. BMI < 15 or > 19, obtained via patient medical chart or from study 2023P000469 or 2018P002915.
  2. HR <55 or >100, obtained via patient medical chart or from study 2023P000469 or 2018P002915.
  3. Systolic BP (SBP and DBP) <80 or >160, obtained via patient medical chart or from study 2023P000469 or 2018P002915.
  4. Temperature < 96.5 F, obtained via patient medical chart or from study 2023P000469 or 2018P002915.
  5. Not eating food by mouth and/or any tube feeding, per EDE
  6. Purging > 4x/week, per EDE.
  7. Active suicidality (suicidal ideation with intent or plan) to the point that more intensive treatment (i.e. acute hospitalization) is required
  8. Active untreated and unstable bipolar disorder (i.e. stable bipolar disorder under care of a psychiatrist is allowed)
  9. Psychosis
  10. Intellectual disability
  11. Any condition that, after the baseline evaluation, is determined to preclude treatment with CBT.
  12. Concurrent psychotherapy. Patients must be willing to take a pause from any ongoing psychotherapy in order to focus on CBT-AN-20, which is in alignment with standard clinical care.
  13. Symptoms that are not appropriate for outpatient level of care and therefore require a higher level of care (i.e. BMI <15 or purging more than 4x/week)
  14. Homicidal ideation
  15. Inability to speak English well enough to engage in CBT

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

20 participants in 1 patient group

CBT-20-AN
Experimental group
Description:
The single CBT-20-AN arm of this study is experimental, consisting of 20 weekly sessions and one-month, three-month, and six-month follow-ups.
Treatment:
Behavioral: Twenty Session Cognitive-Behavioral Therapy for Anorexia Nervosa (CBT-20-AN)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems